Today: 8 February 2026
Subscribe
Browse Category

NYSE:HUM News 25 November 2025 - 5 January 2026

UnitedHealth stock ticks up after Barclays target hike as UNH earnings near

UnitedHealth stock ticks up after Barclays target hike as UNH earnings near

UnitedHealth shares rose 0.8% to $338.94 in late-morning trading Monday after Barclays raised its price target to $391 and reiterated an Overweight rating. Investors are watching ahead of Jan. 27, when UnitedHealth will report 2025 results and 2026 guidance. Scrutiny remains on medical-cost trends, operational review progress, and ongoing Justice Department investigations into Medicare Advantage billing.
5 January 2026
·····
UnitedHealth stock rises into the weekend — what UNH investors watch before Jan. 27 results

UnitedHealth stock rises into the weekend — what UNH investors watch before Jan. 27 results

UnitedHealth Group shares rose 1.9% to $336.40 Friday, trading 6.9 million shares and closing above key moving averages. The company will report full-year results and its 2026 outlook before the market opens Jan. 27. UnitedHealth remains under Justice Department investigation over billing practices. The stock is well below its 52-week high of $606.36.
5 January 2026
····
UnitedHealth Group (UNH) Stock After Hours Today (Dec. 15, 2025): Key News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

UnitedHealth Group (UNH) Stock After Hours Today (Dec. 15, 2025): Key News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

UnitedHealth (UNH) closed Monday down 0.22% at $341.10 and slipped to $340.14 after hours. The move followed Fitch’s downgrade of rival Humana, citing higher medical costs and weaker Medicare Advantage bonuses. UNH traded 6.3 million shares in a $337–$344.96 range. Industry commentary remains focused on rising expenses and regulatory pressure.
16 December 2025
···
Humana Stock (HUM) Outlook December 4, 2025: Earnings Beat, Legal Risks and 2026 Medicare Advantage Forecast

Humana Stock (HUM) Outlook December 4, 2025: Earnings Beat, Legal Risks and 2026 Medicare Advantage Forecast

Humana shares traded in the mid-$250s on December 4, down 12% over the past year and 18% below their September high. The stock is up just 1.3% year to date, lagging the SPDR S&P Health Care Services ETF’s nearly 20% gain. Institutional investors, including Norges Bank, increased stakes in 2025, with about 92% of shares now institutionally held. Regulatory headlines and guidance changes have driven sharp price swings.
4 December 2025
··
PSTV Stock on November 25, 2025: FDA Meeting, Nasdaq Extension and Humana Deal Put Plus Therapeutics Back in Focus

PSTV Stock on November 25, 2025: FDA Meeting, Nasdaq Extension and Humana Deal Put Plus Therapeutics Back in Focus

As traders log in on Tuesday, November 25, 2025, Plus Therapeutics (NASDAQ:PSTV) is back on the radar thanks to a cluster of late‑November catalysts: an FDA Type B meeting for lead radiotherapeutic REYOBIQ™, a fresh 180‑day Nasdaq bid‑price extension, and a national coverage agreement with Humana for its CNSide® cancer diagnostic. As of the latest completed trading session on Monday, November 24, PSTV last changed hands at $0.5752, up roughly 8% on the day, after trading between $0.50 and $0.59 on volume of about 8.4 million shares. Even after that bounce, the stock still sits well below its 52‑week high
25 November 2025
·
1 2

Stock Market Today

Barclays share price jumps into earnings week: what to watch before Tuesday’s results

Barclays share price jumps into earnings week: what to watch before Tuesday’s results

8 February 2026
Barclays shares closed up 2.71% at 479.1 pence on Friday, ahead of full-year results and a targets update due Tuesday. Barclays and NatWest have both submitted offers for Evelyn Partners, with a deal announcement possible this week, according to Reuters. Mary Francis will retire from the Barclays board in May. Investors are watching for signals on costs, credit quality, and capital returns.
Rolls-Royce share price ends week higher on buyback update as RR.L eyes turn to results

Rolls-Royce share price ends week higher on buyback update as RR.L eyes turn to results

8 February 2026
Rolls-Royce Holdings shares closed at 1,229p on Friday, up 1.78%, as the FTSE 100 gained 0.59%. The company reported buying 742,570 shares on Feb. 5 as part of its £200 million buyback, bringing total repurchases to 12.66 million shares. Rolls-Royce will attend the World Defense Show in Riyadh, noting over 80% of its Saudi workforce are nationals.
Vodafone share price: Buyback kicks off, but Germany recovery is the next test for VOD.L

Vodafone share price: Buyback kicks off, but Germany recovery is the next test for VOD.L

8 February 2026
Vodafone (VOD.L) bought 27.1 million shares this week as its new buyback began, with the stock closing Friday up 1.47% at 110.6p after a sharp drop the day before. Investors remain focused on Germany’s service-revenue growth and the pace of buybacks ahead of Monday’s open. The company maintained full-year guidance after reporting 5.4% group service revenue growth in Q3, with Germany up 0.7%.
Go toTop